Medtronic (XSWX:MDT) Current Accrued Expense: CHF2,862 Mil (As of Apr. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSWX:MDT Medtronic PLC XSWX:MDT
76 GF Score
Price CHF69.82
GF Value CHF80.28
! 3 Warning Signs
View Full Analysis

What is Medtronic Current Accrued Expense?

Medtronic XSWX:MDT 76 Current Accrued Expense is CHF2,862 Mil as of Apr. 2026. GuruFocus rates XSWX:MDT with a GF Score™ of 76/100 and a GF Value™ of CHF80.28. The stock has 3 warning signs investors should review.

Medtronic's Current Accrued Expense for the quarter that ended in Apr. 2026 was CHF2,862 Mil.

Medtronic's quarterly Current Accrued Expense increased from Oct. 2025 (CHF2,515 Mil) to Jan. 2026 (CHF2,766 Mil) and increased from Jan. 2026 (CHF2,766 Mil) to Apr. 2026 (CHF2,862 Mil).

Medtronic's annual Current Accrued Expense declined from Apr. 2024 (CHF3,259 Mil) to Apr. 2025 (CHF3,071 Mil) and declined from Apr. 2025 (CHF3,071 Mil) to Apr. 2026 (CHF2,862 Mil).

Medtronic Current Accrued Expense Historical Data

* Premium members only.

The historical data trend for Medtronic's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medtronic Current Accrued Expense Chart

Medtronic Annual Data
Trend Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24 Apr25 Apr26
Current Accrued Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3,355.70 3,217.53 3,259.26 3,070.52 2,862.14

Medtronic Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Current Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3,070.52 2,872.85 2,514.52 2,766.06 2,862.14
XSWX:MDT
76GF Score
Medtronic PLC XSWX:MDT
Current Accrued Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medtronic Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

What does a Current Accrued Expense of CHF2,862 Mil mean?
Medtronic (XSWX:MDT) has a Current Accrued Expense of CHF2,862 Mil as of Apr. 2026. Current Accrued Expense records the total amount of accrued expenses. View historical data on Medtronic and its competitors.
Is Medtronic's Current Accrued Expense too high?
Medtronic's current Current Accrued Expense is CHF2,862 Mil. Overall, Medtronic has a GF Score™ of 76/100, reflecting its overall financial health beyond just this single metric.
How does Medtronic's Current Accrued Expense compare to SYK and BSX?
Medtronic's Current Accrued Expense of CHF2,862 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Accrued Expense for a Medical Devices & Instruments company?
A good Current Accrued Expense depends on the Medical Devices & Instruments industry context. However, Current Accrued Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Accrued Expense mean?
A high Current Accrued Expense can signal that a stock is expensive relative to its fundamentals. Current Accrued Expense records the total amount of accrued expenses. View historical data on Medtronic and its competitors. Medtronic's current Current Accrued Expense is CHF2,862 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medtronic stock overvalued right now?
Medtronic (XSWX:MDT) has a current Current Accrued Expense of CHF2,862 Mil. The stock's GF Value™ is CHF80.28, compared to a current price of CHF69.82 — trading 13% below its estimated fair value. The current Current Accrued Expense is CHF2,862 Mil. Medtronic's overall GF Score™ is 76/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Accrued Expense calculated?
Current Accrued Expense is calculated from a company's financial statements. For Medtronic (XSWX:MDT), the current Current Accrued Expense is CHF2,862 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medtronic (XSWX:MDT) Overvalued in 2026?

Based on GuruFocus' analysis, Medtronic stock appears to be undervalued. The current stock price of CHF69.82 is trading 13% below its estimated GF Value™ of CHF80.28.

Key valuation signals for XSWX:MDT:

  • Current Accrued Expense: CHF2,862 Mil
  • GF Value™: CHF80.28 vs. price of CHF69.82 (13% below fair value)
  • GF Score™: 76/100 with 3 warning signs

No single metric tells the full story. See the XSWX:MDT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medtronic Business Description

Address Parkmore Business Park West, Building Two, Galway, IRL
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.
76GF Score

Get the complete analysis for XSWX:MDT

Current Accrued Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF69.82
Price
CHF80.28
GF Value